1. Correction to Lancet Gastroenterol Hepatol 2018; 4: 435–44
The Lancet Gastroenterology & Hepatology 
Volume 4, Issue 6, (June 2019)
DOI: /S (19)
Copyright © 2019 Elsevier Ltd Terms and Conditions

2. Figure 3
Map of PAF of HCV transmission associated with injection drug use, 2018–30
PAF is the percentage of all new HCV infections that would be prevented over the period 2018–30 if the additional HCV transmission risk attributable to IDU was removed. Countries in grey were not modelled because of a paucity of data. PAF=population attributable fraction. HCV=hepatitis C virus. IDU=injection drug use.
The Lancet Gastroenterology & Hepatology 2019 4, DOI: ( /S (19) )
Copyright © 2019 Elsevier Ltd Terms and Conditions